Stockreport

Biogen: Why I Anticipate A Difficult 2026 For 'End Of An Era' Pharma [Seeking Alpha]

Biogen Inc.  (BIIB) 
Last biogen inc. earnings: 4/22 07:12 am Check Earnings Report
US:NASDAQ Investor Relations: biogen.com/en_us/investors.html
PDF MS franchise erosion accelerates with patent expiries and generic Tysabri, while new products and pipeline assets lack clear blockbuster potential. Leqembi and other [Read more]